Interferons Can Upregulate the Expression of the Tumor Associated Antigen G250-MN/CA IX, a Potential Target for (Radio)Immunotherapy of Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Interferons Can Upregulate the Expression of the Tumor Associated Antigen G250-MN/CA IX, a Potential Target for (Radio)Immunotherapy of Renal Cell Carcinoma

Published:2003-08 Issue:4 Volume:18 Page:539-547
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Brouwers Adrienne H.¹,Frielink Cathelijne¹,Oosterwijk Egbert²,Oyen Wim J.G.¹,Corstens Frans H.M.¹,Boerman Otto C.¹

Affiliation:

1. Department of Nuclear Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands

2. University Medical Center Nijmegen, Nijmegen, The Netherlands

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/108497803322287619

Reference36 articles.

1. Cancer statistics, 2000

2. A New Protocol for the Followup of Renal Cell Carcinoma Based on Pathological Stage

3. Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbonic Anhydrase IX: A Renewed Target for Cancer Immunotherapy;Cancers;2022-03-09

2. Carbonic Anhydrase IX: Current and Emerging Therapies;Progress in Drug Research;2021

3. Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges;Expert Opinion on Drug Delivery;2017-09-12

4. Carbonic Anhydrase IX and Monoclonal Antibody G250: Relevance as a Clinical and Biologic Target in Renal Cell Carcinoma;Renal Cell Carcinoma;2014-11-01

5. Monoclonal antibody G250 targeting CA IX: Binding specificity, internalization and therapeutic effects in a non-renal cancer model;International Journal of Oncology;2014-09-17